The Oct. 26, 2017 arrest of John Kapoor, Insys Therapeutics’ founder, CEO and majority owner, on federal fraud and conspiracy charges, happened the same day the Trump administration formally proclaimed a stance against opioids. That coincidence was rich with irony for cannabis observers.
The Chandler, Arizona-based company manufactures and markets the extremely potent fentanyl spray Subsys, as well as the synthetic-THC spray Syndros.
Update: On May 2, 2019, Kapoor and four others were found guilty of a racketeering conspiracy after a 10-week trial in Boston federal court. The jury deliberated for 15 days. Kapoor faces a potential 20-year sentence.
Kapoor – a self-made Indian-American pharmaceutical billionaire – and six former Insys executives were charged with “RICO conspiracy, as well as other felonies, including conspiracy to commit mail and wire fraud… and conspiring to bribe practitioners in various states, many of who operated pain clinics, in order to get them to prescribe a fentanyl-based pain medication (‘Subsys’), a powerful narcotic intended to treat cancer patients suffering intense breakthrough pain,” the Department of Justice stated. “In exchange for bribes and kickbacks, the practitioners wrote large numbers of prescriptions for the patients, most of whom were not diagnosed with cancer.” The indictment also